At this point I'll be asking the same scratched record that has been asked for over a decade.
Why did Biota let GSK get away with blocking any progress researching I.V. zanamivir, which has never indicated any problems using injected Relenza at ANY AGE?
Why did Biota let GSK's patented Diskhaler make more profit for GSK, and more death for the young and elderly who couldn't use the crap medicine delivery system.
GSK is still sticking to the "men's only club" handshake with Roche, designed years before bird flu was even a problem.
GSK GETS VACCINES, ROCHE GETS ANTIVIRALS(never mind Biota gets shafted).
A cosy agreement that was secret and convenient years ago(before birdflu) but is constantly pressured by the increasing insanity and attention that the absurd behaviour of GSK can not be explained in any other way.
"gsk advise governments 30 to 50% relenza"
GSK may be advising 50% relenza, but what is actually available, and is it O.K. with Roche?
BTA Price at posting:
$1.28 Sentiment: Hold Disclosure: Held
